Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- YAYA SCIENTIFIC LLC
- Proposal award date
- 2020-09-21
- Contract end date
- 2021-09-20
- UEI
- XJ5YP74TJTN7
- Solicitation number
- PA19-270
- Topic code
- NIBIB
Research abstract
PROJECT SUMMARY
We propose to develop a novel non-contact, label-free multimodality imager that provides real-time intraoperative
identification of nerves within the surgical field-of-view to facilitate the prevention of unintended nerve damage
(termed iatrogenic nerve injury) during surgical procedures, as they are a major source of postsurgical
complications, e.g., chronic pain. In the United States chronic pain management is a major putative contributing
factor in the current opioid-related drug overdose epidemic. Annually, over 45 million surgical procedures are
performed in the United States and an estimated 10% to 50% of them result in patient chronic postoperative pain
outcomes. Though not all the at least 4.5 million are definitively ascribable to iatrogenic nerve injury, it
nonetheless represents a significant recurring annual healthcare problem. Relatedly, analysis of large-scale
nerve lesion treatment studies reveals that 25%, 60% and 94% respectively of sciatic, femoral and accessory
nerve lesions addressed are caused by iatrogenic nerve injury.
Additionally, iatrogenic nerve injury features prominently in post-surgical quality of life issues that range from
loss of sensation and motor function, to the aforementioned chronic pain, and morbidity. Reportedly, 2-3 years
post radical prostatectomy ~60% of men are still impotent as a result of damaged cavernous nerves. Likewise,
20% - 60% of mastectomy breast cancer treatment survivors suffer chronic post-surgical pain that significantly
reduces their quality of life, and injury to the intercostobrachial nerve is the primary cause. Even in surgeries with
minimal neural damage risk like acoustic neuroma removal (andlt;1%), spinal scoliosis surgery (andlt;0.6%), and
thyroidectomy (andlt;2-3.8%) the consequences of nerve damage can be severe: leading to deafness, paraplegia,
and even death respectively. The associated financial implications of iatrogenic nerve damage are significant.
There are direct financial costs to the individual due to loss of employment and/or income, and to the healthcare
industry as nerve damage is a common source of litigation with compensation being awarded in 82% of cases
of spinal accessory nerve injury, for an example. The exposure of healthcare personnel and providers to
medicolegal liability is extensive as Iatrogenic nerve injuries are commonly reported on the laryngeal nerve
during thyroid operations, trigeminal nerve and inferior alveolar nerve during facial and oral surgeries, intercostal
nerves during thoracic surgeries, and on the spinal accessory nerves, common peroneal nerve, superficial radial
nerve, and genitofemoral nerve branches during various other surgeries. Consequently, as of 2015, medicolegal
litigation risk was a primary driver for a $2.2 billion global market for intraoperative nerve monitoring projected to
grow annually at 4.79% until 2025. Our proposed solution targets filling both the deficiencies of currently available
options and the growing demand by introducing an effective, commercially viable product.PROJECT NARRATIVE
Unintended nerve damage during surgical procedures is a significant and costly public healthcare delivery
problem and current methods for injury prevention via intraoperative nerve monitoring leave substantial room
for improvement. The ramifications of increased healthcare costs due to associated medical-liability issues and
the significant reductions in quality of life issues, including the burgeoning chronic pain management related
opioid-related drug overdose epidemic, make addressing this very impactful to society. The proposed
development will yield an effective, commercially viable, non-contact multimodality imager that provides real-
time intraoperative identification of nerves within the surgical field-of-view to facilitate the prevention of
unintended nerve damage during surgical procedures.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
3 SBIR/STTR records share this UEI (2020–2023). Reported award amounts total $2,772,550. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards